Cargando…
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
BACKGROUND: Neuroendocrine carcinoma (NEC) arising from the esophagus (EsoNEC) is extreme rare, accounting for approximately 1% of esophageal cancer. Even for localized NEC, multidisciplinary approach including chemotherapy is recommended in treatment guidelines because of its high rates of systemic...
Autores principales: | Honma, Yoshitaka, Nagashima, Kengo, Hirano, Hidekazu, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Boku, Narikazu, Murakami, Naoya, Inaba, Kouji, Ito, Yoshinori, Itami, Jun, Kanamori, Jun, Oguma, Junya, Daiko, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970034/ https://www.ncbi.nlm.nih.gov/pubmed/31794158 http://dx.doi.org/10.1002/cam4.2708 |
Ejemplares similares
-
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report
por: Watanabe, Sho, et al.
Publicado: (2019) -
Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer
por: Aoki, Masahiko, et al.
Publicado: (2019) -
Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab
por: Kadono, Toru, et al.
Publicado: (2023) -
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer
por: Oshima, Kotoe, et al.
Publicado: (2022) -
Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy
por: Tamura, Nobumasa, et al.
Publicado: (2020)